ARCHIVES

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

Tamoxifen Trial may EB Funded In Part With CCOP Money

March 22, 1991

NIH Director Collins Publishes Third Book About Faith In God

March 5, 2010

New Drug Combination Shrinks Kidney Cancers

June 30, 2006

In Brief: Junqueira Of Brazil Named Next UICC President, Murphy Gets Another Term as Secretary General

September 5, 1980

RFA On Hepatitis B Virus, Liver Cancer

April 15, 1983

In Brief: Schmidt Confers With Califano, Fredrickson On NCI director; Senate Hearing March 15-16

February 18, 1977